|
|
CN
Online Message×
Click switch
News information
A seminar on preclinical R&D strategic cooperation was held between Medicilon and Yichang Humanwell
2020-08-20
|
Page View:

Yichang, Hubei, Aug 13, 2020 – A seminar on preclinical R&D strategic cooperation was held between Medicilon. INC (Stock Code: 688202. SH) and Yichang Humanwell Pharmaceutical CO.LTD (Stock Code: 600079. SH). During the meeting, the two companies discussed the vision of cooperation in the future, hoping to strengthen the relationship, jointly promote the research and development process, and provide better choices for doctors and patients to cure diseases.

 A seminar on preclinical R&D strategic cooperation was held between Medicilon and Yichang Humanwell
Relevant news